What Researchers Did
This study described the case of a patient who developed very severe methemoglobinemia after occupational exposure to a chemical.
What They Found
The patient had an unusually high methemoglobin level of 82% and did not improve with standard treatments like methylene blue, red cell exchange, intravenous ascorbic acid, or hyperbaric oxygen. However, the patient recovered completely after receiving plasmapheresis. This suggests plasmapheresis might be an option for severe cases that don't respond to other therapies.
What This Means for Canadian Patients
For Canadian patients experiencing severe methemoglobinemia, especially from occupational exposure, this case suggests that plasmapheresis could be a life-saving treatment if other therapies, including hyperbaric oxygen therapy (HBOT), are not effective. While HBOT is mentioned as a treatment option for methemoglobinemia, this specific case highlights its potential limitations in extremely severe instances.
Canadian Relevance
This study was not conducted by Canadian authors or in Canada. While hyperbaric oxygen therapy (HBOT) is mentioned as a treatment option for methemoglobinemia, methemoglobinemia itself is not a Health Canada-recognized indication for HBOT.
Study Limitations
As a single case report, this study's findings cannot be generalized to all patients with severe methemoglobinemia.